Investigating the role of GTPase in inhibiting HBV replication and enhancing interferon therapy efficacy in chronic hepatitis B patients
Microbial Pathogenesis · 2024
DOI: 10.1016/j.micpath.2024.106821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2024. Verfasst von Dongmei Quan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Surgery, The Sixth People's Hospital of Shenyang, Shenyang, China. Hauptthemen laut MEDLINE: GTP Phosphohydrolases, Hepatitis B Surface Antigens, Hepatitis B virus, Hepatitis B, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Interferon-alpha (IFNα) is a common treatment for chronic hepatitis B virus (HBV) infection, but its efficacy varies widely among patients. GTPASE, an interferon-stimulated gene (ISG), has recently been identified as a factor in antiviral immunity, though its role in HBV infection is not fully understood. OBJECTIVE: This study investigates the role of GTPASE in enhancing the antiviral effects of IFNα against HBV and elucidates its mechanism of action. METHODS: We analyzed the impact of GTPASE overexpression and silencing on HBV replication and clearance in HBV-infected cells. Molecular docking studies assessed the interaction between GTPASE and HBV surface antigens (HBs). Clinical samples from HBV patients undergoing Peg-IFNα treatment were also evaluated for GTPASE expression and its correlation with treatment efficacy. RESULTS: Overexpression of GTPASE led to significant inhibition of HBV replication, increased HBeAg seroconversion, and enhanced HBsAg clearance. GTPASE directly bound to HBs proteins, reducing their levels and affecting viral particle formation. Silencing GTPASE reduced these effects, while combined treatment with Peg-IFNα and GTPASE overexpression further improved antiviral outcomes. Mutational analysis revealed that specific sites in GTPASE are crucial for its antiviral activity. CONCLUSIONS: GTPASE acts as a positive regulator in IFNα-induced antiviral immunity against HBV. It enhances the therapeutic efficacy of IFNα by targeting HBs and modulating viral replication. GTPASE levels may serve as a predictive biomarker for response to Peg-IFNα therapy, highlighting its potential for improving individualized treatment strategies for chronic HBV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatobiliary Surgery, The Sixth People's Hospital of Shenyang, Shenyang, China.
- The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine/Medical Management Office, China.
- Teaching and Research Section of the Internal Medicine of Traditional Chinese Medicine, The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, China. Electronic address: lijinginzy@outlook.com.
Zitieren
APA
Quan, D., Wang, P., Wu, W., & Li, J. (2024). Investigating the role of GTPase in inhibiting HBV replication and enhancing interferon therapy efficacy in chronic hepatitis B patients. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2024.106821
Vancouver
Quan D, Wang P, Wu W, Li J. Investigating the role of GTPase in inhibiting HBV replication and enhancing interferon therapy efficacy in chronic hepatitis B patients. Microbial Pathogenesis. 2024. doi:10.1016/j.micpath.2024.106821
BibTeX
@article{Quan2024,
author = {Quan, Dongmei and Wang, Pengfei and Wu, Wei and Li, Jing},
title = {Investigating the role of GTPase in inhibiting HBV replication and enhancing interferon therapy efficacy in chronic hepatitis B patients},
journal = {Microbial Pathogenesis},
year = {2024},
doi = {10.1016/j.micpath.2024.106821}
}
EUVIMED